Last 47 quarters of trend data · Healthcare · Vaccines & Infectious Disease
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -80.94 | 5.35 | — | — | — | 3.33 | — | 2.35 | 90.24 | 74.41 | 15.29 | 1.37 | — | — | — | — | 5.72 | 96.50 | — | 1.92 | — |
| — | +60.9% | — | — | — | -95.5% | — | +71.0% | — | — | — | — | — | — | — | — | — | — | — | -72.6% | — | |
| P/S Ratio | 4.14 | 1.60 | 15.35 | 28.78 | 62.52 | 1.44 | 13.90 | 1.32 | 12.10 | 6.24 | 6.02 | 0.85 | 10.10 | 15.27 | 12.47 | 11.78 | 2.61 | 12.74 | 12.43 | 1.22 | 28.53 |
| — | +10.7% | +10.5% | +2074.7% | +416.7% | -76.9% | +130.8% | +54.9% | +19.8% | -59.1% | -51.7% | -92.7% | +286.7% | +19.9% | +0.4% | +865.6% | -90.8% | -8.4% | -52.5% | -67.6% | +840.6% | |
| P/B Ratio | 1.12 | 1.58 | 2.53 | 2.20 | 3.22 | 2.23 | 1.81 | 2.00 | 2.86 | 3.25 | 3.71 | 2.02 | 3.01 | 2.89 | 2.56 | 3.14 | 4.36 | 6.08 | 3.12 | 3.23 | 5.19 |
| — | -29.2% | +39.6% | +10.1% | +12.6% | -31.2% | -51.2% | -1.2% | -4.9% | +12.3% | +45.0% | -35.7% | -31.0% | -52.4% | -18.0% | -2.6% | -16.0% | +47.3% | -24.0% | -26.2% | +9.2% | |
| P/FCF | — | 4.31 | — | — | — | 1.85 | 13.91 | 1.92 | — | 22.88 | — | 1.26 | — | — | 4.25 | — | — | — | 2.31 | 8.75 | 84.90 |
| — | +132.5% | — | — | — | -91.9% | — | +52.1% | — | — | — | — | — | — | +83.8% | — | — | — | — | +183.4% | +1881.8% | |
| EV / EBITDA | — | 2.57 | — | — | — | 1.56 | — | 1.21 | 143.81 | 89.74 | 10.28 | 0.68 | — | — | — | — | 3.75 | 57.45 | — | 1.22 | — |
| — | +64.7% | — | — | — | -98.3% | — | +78.5% | — | — | — | — | — | — | — | — | — | -91.9% | — | -70.8% | — | |
| EV / EBIT | 2.87 | 2.43 | — | — | — | 1.51 | — | 1.18 | 51.49 | 45.69 | 8.87 | 0.66 | — | — | — | — | 3.76 | 59.85 | — | 1.23 | — |
| — | +60.9% | — | — | — | -96.7% | — | +78.0% | — | — | — | — | — | — | — | — | — | -99.9% | — | -71.4% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.6% | 57.2% | 52.9% | 21.2% | 61.8% | 68.5% | 97.8% | 82.7% | 83.8% | 43.6% | 75.3% | 85.0% | 50.8% | -3.6% | 25.6% | 35.8% | 86.6% | 53.7% | 21.6% | 84.9% | 31.5% |
| — | -16.5% | -45.9% | -74.4% | -26.3% | +57.3% | +29.8% | -2.8% | +65.0% | +1305.3% | +194.7% | +137.3% | -41.3% | -106.7% | +18.5% | -57.8% | +174.7% | -13.9% | -54.1% | +5.4% | -61.9% | |
| Operating Margin | 25.1% | 33.9% | -85.2% | -250.0% | -390.2% | 56.3% | -32.0% | 70.1% | 5.4% | 5.0% | 44.3% | 78.7% | -14.2% | -78.9% | -25.3% | -15.9% | 59.4% | 18.4% | -13.7% | 81.5% | -60.7% |
| — | -39.8% | -166.1% | -456.8% | -7304.6% | +1037.4% | -172.2% | -11.0% | +138.2% | +106.3% | +275.0% | +595.3% | -123.9% | -528.3% | -85.5% | -119.5% | +197.7% | +144969.3% | +67.0% | +14.7% | -181.7% | |
| Net Margin | 24.6% | 30.4% | -55.3% | -142.1% | -243.0% | 43.7% | -5.8% | 56.2% | 13.4% | 8.4% | 40.4% | 62.0% | -4.3% | -48.9% | -11.0% | -7.1% | 45.8% | 12.2% | -3.4% | 63.5% | -64.2% |
| — | -30.5% | -854.4% | -353.0% | -1909.7% | +420.6% | -114.3% | -9.5% | +415.5% | +117.2% | +466.3% | +967.9% | -109.3% | -500.2% | -222.1% | -111.3% | +171.2% | +525.1% | +79.7% | +18.8% | -217.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.2% | 7.9% | -2.0% | -2.7% | -3.1% | 16.7% | -0.2% | 23.8% | 0.8% | 1.1% | 5.7% | 45.0% | -0.3% | -2.0% | -0.6% | -0.5% | 21.1% | 1.3% | -0.2% | 52.1% | -2.8% |
| — | -52.8% | -943.1% | -111.3% | -486.7% | +1413.4% | -103.3% | -47.2% | +351.8% | +154.8% | +1127.8% | +9619.8% | -101.5% | -251.7% | -161.8% | -100.9% | +857.3% | +837.7% | +67.2% | +213.8% | -111.9% | |
| ROA | 10.0% | 6.3% | -1.6% | -2.4% | -2.7% | 14.7% | -0.2% | 20.8% | 0.7% | 0.8% | 4.1% | 35.0% | -0.3% | -1.7% | -0.5% | -0.4% | 18.1% | 1.2% | -0.2% | 41.8% | -2.3% |
| — | -57.1% | -847.7% | -111.5% | -493.6% | +1649.2% | -104.0% | -40.6% | +368.7% | +148.3% | +952.6% | +8711.2% | -101.4% | -247.2% | -167.9% | -101.0% | +884.7% | +852.3% | +67.9% | +201.9% | -112.5% | |
| ROIC | 33.7% | 38.0% | -15.6% | -18.5% | -25.6% | 83.7% | -2.9% | 65.0% | 0.6% | 2.0% | 24.5% | 136.3% | -1.9% | -7.3% | -2.7% | -2.0% | 71.7% | 11.3% | -2.5% | 164.2% | -13.4% |
| — | -54.6% | -432.2% | -128.5% | -4253.3% | +4177.8% | -111.9% | -52.3% | +132.0% | +126.8% | +1022.5% | +6940.2% | -102.7% | -164.5% | -6.8% | -101.2% | +634.5% | +240638.3% | +75.9% | +92.4% | -120.7% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -2.5% | +62.8% | +18.1% | +42.3% | -12.9% | -15.3% | -11.6% | -29.3% | -28.9% | -7.8% | -7.7% | +49.0% | +21.2% | +14.1% | +15.9% | -35.7% | -2.3% | -9.6% | -22.8% | +19.1% | |
| Debt / EBITDA | 0.02 | 0.03 | — | — | — | 0.01 | — | 0.01 | 0.80 | 0.43 | 0.04 | 0.01 | — | — | — | — | 0.01 | 0.16 | — | 0.00 | — |
| — | +151.1% | — | — | — | -97.1% | — | +55.6% | — | — | — | — | — | — | — | — | — | -95.1% | — | -70.3% | — | |
| Current Ratio | 11.83 | 21.72 | 3.25 | 11.83 | 9.17 | 10.09 | 8.40 | 9.12 | 8.10 | 8.25 | 3.05 | 4.42 | 4.75 | 7.07 | 9.34 | 8.63 | 7.17 | 9.20 | 24.46 | 6.85 | 6.81 |
| — | +115.3% | -61.4% | +29.7% | +13.2% | +22.2% | +175.9% | +106.5% | +70.6% | +16.7% | -67.4% | -48.9% | -33.8% | -23.2% | -61.8% | +26.1% | +5.4% | -42.3% | +38.3% | -50.0% | -15.4% | |
| Quick Ratio | 9.10 | 16.48 | 2.38 | 9.10 | 7.24 | 8.52 | 6.28 | 7.16 | 5.32 | 5.65 | 2.19 | 3.23 | 2.64 | 4.41 | 7.03 | 6.81 | 6.03 | 8.22 | 22.21 | 6.21 | 5.24 |
| — | +93.4% | -62.1% | +27.1% | +36.0% | +50.8% | +186.1% | +121.8% | +101.9% | +28.0% | -68.8% | -52.6% | -56.3% | -46.3% | -68.3% | +9.7% | +15.1% | -39.0% | +48.3% | -47.2% | -29.0% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | 105.27 | — | — | — | -0.49 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SIGA stock.
SIGA Technologies, Inc.'s current P/E is -80.9x. The average P/E over the last 1 quarters is 5.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
SIGA Technologies, Inc.'s current operating margin is 25.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking SIGA Technologies, Inc.'s business trajectory between earnings reports.